As in the case of ATO, the anti-apoptotic/pro-apoptotic protein ratio was elevated, suggesting that the protective effect of MMP-9 against apoptosis may be a general CLL cell response to cytotoxic drugs. This evidence concerns the gene MMP9 and B-cell chronic lymphocytic leukemia.